Lu Li

Lu Li is an experienced investment analyst currently at OneVentures, focusing on scaling technology and healthcare companies through growth equity and credit since May 2022. Prior to this role, Lu served as a technical consultant and scientific writer at DeepTech from July 2020 to May 2022, and as an equity research analyst at CITIC Securities Company Limited in early 2019. Lu's academic background includes a PhD in Microbiology and Immunology from the University of Connecticut, where extensive research involved designing experimental protocols, collaborating with the scientific community, and mentoring undergraduate researchers. Teaching assistantship experience involved leading lab sessions and evaluating student performance in courses such as Anatomy & Physiology and Pathology.